Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: A 2-year follow-up

Transplant International

Volumn 15, Issue 8, 2002, Pages 387-392

  Ducloux, Didier ^a   Motte, Gérard ^a   Billerey, Claude ^b   Bresson Vautrin, Catherine ^a   Vautrin, Pierre ^a   Rebibou, Jean Michel ^a   Saint Hillier, Yves ^a   Chalopin, Jean Marc ^a  

^a HÔPITAL SAINT JACQUES   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Cyclosporin withdrawal; Mycophenolate mofetil; Renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADULT; ANEMIA; ARTICLE; BACTEREMIA; BLOOD PRESSURE REGULATION; BREAST CANCER; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE COURSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HISTOLOGY; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LUNG CANCER; MALE; NEPHROTOXICITY; PNEUMONIA; PRIORITY JOURNAL; PROTEINURIA; PYELONEPHRITIS; RECTUM CANCER; TOXOPLASMOSIS;

ADULT; AGED; AZATHIOPRINE; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036940552     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00186.x     Document Type: Article

References (21)

1. Allison A, Eugui E, Sollinger H (1993) Mycophenolate mofetil (RS-61443): Mechanisms of action and effects in transplantation. Transplant Rev 7:129-139
2. Belitsky P, Gulanikar A, He G, Gupta R (1993) The effect of immunosuppression on chronic rejection in the rat aortic allograft model. Transplant Proc 25:935
3. Bia MJ (1995) Non immunologic causes of late renal graft loss. Kidney Int 47:1470
4. Cheigh JS, Haschemeyer RH, Wang JCL, Riggio RR, Tapia L, Stenzel KH, Rubin AL (1989) Hypertension in kidney transplant recipients. Effects on long-term allograft survival. Am J Hypertens 2:341-348
5. Ducloux D, Carron PL, Rebibou JM, Aubin F, Fournier V, Bresson-Vautrin C, Blanc D, Humbert P, Chalopin JM (1998) CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 65:1270-1272
6. Ducloux D, Fournier V, Bresson-Vautrin C, Rebibou JM, Billerey C, Saint-Hillier Y, Chalopin JM (1998) Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity. Transplantation 65:1504-1506
7. European Multicentre Trial Group (1983) Cyclosporin in cadaveric renal transplantation: One-year follow-up of a multicentre trial. Lancet 2:986-989
8. First MR, Vaidya PN, Maryniak RK, Weiss MA, Munda R, Fidler JP, Penn I, Alexander JW (1984) Proteinuria following transplantation. 38:607-612
9. Halloran P, Tomlanovich MS, Hooftman CGL (1997) Mycophenolate mofetil in renal allograft recipients. Transplantation 63:39
10. Hostetter TH (1994) Chronic transplant rejection. Kidney Int 46:266-279
11. Hueso M, Bover J, Seron D (1998) Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function. Transplantation 66:1727
12. Kasiske BL, Heim-Duthoy KL, Tortorice KL, Rao KV (1991) The variable nature of chronic declines in renal allograft function. Transplantation 51:330-334
13. Kasiske BL, Kalil RSN, Lee HS, Rao KV (1991) Histopathologic findings associated with a progressive decline in renal allograft function. Kidney Int 40:514-524
14. Massy ZA, Guijarro C, Wiederkehr MR, Ma JZ, Kasiske BL (1996) Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors. Kidney Int 49:518-524
15. Modena FM, Hostetter TH, Salahudeen AK, Najarian JS, Matas AJ, Rosenberg ME (1991) Progression of kidney disease in chronic renal transplant rejection. Transplantation 52:239-244
16. Remuzzi G, Zoja C, Gagliardini, E, Corna D, Abbate M, Benigni A (1999) Combining an antiproteinuric approach with mycophenolate mofetil suppresses progressive nephropathy of experimental animals. J Am Soc Nephrol 10:1542-1549
17. Romero F, Rodriguez-Iturbe B, Parra G, Gonzales L, Herrera-Acosta J, Tapia E (1999) Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 55:945-955
18. Schurter G, Glicklich D, Greenstein S (1997) Mycophenolate mofetil therapy for chronic rejection in renal transplant recipients (abstract). Am Society Transplant Physicians Abstr Book: 16:134 (196A)
19. Smith M, Newby B, Rao R (1997) Response to MMF in patients with chronic renal allograft rejection. (abstract). Am Society Transplant Physicians Abstr Book: 16:134 (197A)
20. The Canadian Multicentre Transplant Study Group (1983) A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 309:809-815
21. Weir MR, Anderson L, Fink JC (1997) A novel approach to the treatment of chronic allograft nephropathy. Transplantation 64:1706